| Financial Year |
March 31 2023 |
| Monetary Funds |
4,447,668,081.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,337,219.89 |
| Accounts Receivable |
4,360,329,510.88 |
| Advances to Suppliers |
532,777,598.61 |
| Other Receivables |
509,691,514.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,966,402,658.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
358,808,889.62 |
| Total Current Assets |
14,578,253,396.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,131,354.43 |
| Investment Properties |
60,171,090.59 |
| Fixed Assetes |
2,180,544,704.90 |
| Under-construction Projects |
1,075,065,846.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
696,160,416.72 |
| R&D expenses |
-- |
| Goodwill |
603,884,092.62 |
| Long-Term Deferred and Prepaid Expenses |
2,203,909.39 |
| Deferred Income Tax Assets |
278,811,620.77 |
| Other Non-Current Assets |
264,438,777.26 |
| Sub-Total of Non-Current Assets |
5,355,399,944.28 |
| Total Assets |
19,933,653,341.08 |
| Short-Term Loans |
5,426,096,689.97 |
| Trading Financial liabilities |
98,196.84 |
| Notes Payable |
510,449,097.80 |
| Accounts Payable |
4,503,767,271.62 |
| Accounts Received In Advance |
59,888,436.07 |
| Employee Compensation Payable |
130,983,559.51 |
| Taxes Payable |
180,551,165.32 |
| Interest Payable |
-- |
| Dividend Payable |
208,650.12 |
| Other payables |
778,513,651.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
387,358,578.84 |
| Other Current Liabilities |
357,736,518.79 |
| Sub-Total of Current Liabilities |
13,571,667,816.75 |
| Long-term Loans |
775,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
615,412,209.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
46,113,823.82 |
| Deferred Income Tax Liabilities |
12,616,461.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,791,989,583.46 |
| Total Liabilities |
15,363,657,400.21 |
| Paid-In Capital(Or Share Stock) |
2,219,352,746.00 |
| Capital Surplus |
1,263,075,064.80 |
| Surplus Reserve |
225,475,299.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
727,653,439.56 |
| Minority Stockholder's Interest |
134,589,196.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,435,406,744.26 |
| Owner's Equity（Stockholder's Equity） |
4,569,995,940.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,933,653,341.08 |
